|
ERP44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.313600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.015400E-01 |
| Normal-vs-Stage2 |
5.522400E-01 |
| Normal-vs-Stage3 |
7.365800E-01 |
| Normal-vs-Stage4 |
2.320600E-01 |
| Stage1-vs-Stage2 |
2.251400E-01 |
| Stage1-vs-Stage3 |
6.633400E-01 |
| Stage1-vs-Stage4 |
8.123600E-01 |
| Stage2-vs-Stage3 |
4.632200E-01 |
| Stage2-vs-Stage4 |
2.687800E-01 |
| Stage3-vs-Stage4 |
6.024000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.222400E-01 |
| Normal-vs-AfricanAmerican |
6.679800E-01 |
| Normal-vs-Asian |
9.544800E-01 |
| Caucasian-vs-AfricanAmerican |
2.941800E-01 |
| Caucasian-vs-Asian |
8.925800E-01 |
| AfricanAmerican-vs-Asian |
8.098400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.297400E-01 |
| Normal-vs-Female |
4.873200E-01 |
| Male-vs-Female |
1.061780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.059000E-01 |
| Normal-vs-Extreme_Weight |
5.160600E-01 |
| Normal-vs-Obese |
9.871400E-01 |
| Normal-vs-Extreme_Obese |
6.144600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.499000E-01 |
| Normal_Weight-vs-Obese |
2.765400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.107000E-01 |
| Extreme_Weight-vs-Obese |
5.916000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.245600E-01 |
| Obese-vs-Extreme_Obese |
6.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.537200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.198400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.784000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.199000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.310000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.563000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.269400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.016500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.098800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.442200E-01 |
| Normal-VS-Type2 PRCC |
3.124200E-02 |
| Normal-VS-KIRP CIMP |
1.372000E-01 |
| Normal-VS-Unclassified PRCC |
6.600600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.242700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.438210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.969400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.917550E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.230600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.522000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.073000E-01 |
| Normal-vs-N1 |
6.322400E-01 |
| Normal-vs-N2 |
6.418200E-01 |
| N0-vs-N1 |
2.056800E-01 |
| N0-vs-N2 |
8.702800E-01 |
| N1-vs-N2 |
4.277800E-01 |
|
|
